These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25267897)

  • 1. Pharmacological interventions for schizotypal personality disorder.
    Farooq S; Völlm BA; Husain N; Huband N; Stoffers J; Gibbon S; Duggan C; Ferriter M; Lieb K
    Cochrane Database Syst Rev; 2011; (3):. PubMed ID: 25267897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between religiosity domains and traits from borderline and schizotypal personality disorders in a Brazilian community sample.
    Carvalho LF; Sagradim DEV; Pianowski G; Gonçalves AP
    Trends Psychiatry Psychother; 2020; 42(3):239-246. PubMed ID: 33084801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for paranoid personality disorder.
    Völlm BA; Farooq S; Jones H; Ferriter M; Gibbon S; Stoffers J; Duggan C; Huband N; Lieb K
    Cochrane Database Syst Rev; 2011; (5):. PubMed ID: 25267902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor Validity of the DSM-IV Schizoid Personality Disorder Construct as a Diagnostic Category.
    Hummelen B; Pedersen G; Wilberg T; Karterud S
    J Pers Disord; 2015 Jun; 29(3):334-46. PubMed ID: 25248009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of schizophrenia disorders: perspectives from the spectrum.
    Siever LJ; Davis KL
    Am J Psychiatry; 2004 Mar; 161(3):398-413. PubMed ID: 14992962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiological and therapeutic aspects of schizoid and schizotypal personality disorder].
    Sass H; Jünemann K
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S120-6. PubMed ID: 11533862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metacognitively oriented psychotherapy for schizotypal personality disorder: A two-case series.
    Cheli S; Lysaker PH; Dimaggio G
    Personal Ment Health; 2019 Aug; 13(3):155-167. PubMed ID: 31169366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [French validation of the Revised Paranormal Belief Scale].
    Bouvet R; Djeriouat H; Goutaudier N; Py J; Chabrol H
    Encephale; 2014 Sep; 40(4):308-14. PubMed ID: 24836860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia.
    Matsui M; Sumiyoshi T; Kato K; Yoneyama E; Kurachi M
    Psychol Rep; 2004 Apr; 94(2):387-97. PubMed ID: 15154161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients.
    Siever LJ; Silverman JM; Horvath TB; Klar H; Coccaro E; Keefe RS; Pinkham L; Rinaldi P; Mohs RC; Davis KL
    Arch Gen Psychiatry; 1990 Jul; 47(7):634-40. PubMed ID: 2360857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual perception and working memory in schizotypal personality disorder.
    Farmer CM; O'Donnell BF; Niznikiewicz MA; Voglmaier MM; McCarley RW; Shenton ME
    Am J Psychiatry; 2000 May; 157(5):781-8. PubMed ID: 10784472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance in schizotypal personality disorder: importance of working memory.
    Mitropoulou V; Harvey PD; Zegarelli G; New AS; Silverman JM; Siever LJ
    Am J Psychiatry; 2005 Oct; 162(10):1896-903. PubMed ID: 16199836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An MRI study of superior temporal gyrus volume in women with schizotypal personality disorder.
    Dickey CC; McCarley RW; Voglmaier MM; Niznikiewicz MA; Seidman LJ; Demeo S; Frumin M; Shenton ME
    Am J Psychiatry; 2003 Dec; 160(12):2198-201. PubMed ID: 14638590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder.
    Weinstein DD; Diforio D; Schiffman J; Walker E; Bonsall R
    Am J Psychiatry; 1999 Apr; 156(4):617-23. PubMed ID: 10200743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders.
    Silverman JM; Siever LJ; Horvath TB; Coccaro EF; Klar H; Davidson M; Pinkham L; Apter SH; Mohs RC; Davis KL
    Am J Psychiatry; 1993 Mar; 150(3):435-42. PubMed ID: 8434659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.
    Cadenhead KS; Geyer MA; Braff DL
    Am J Psychiatry; 1993 Dec; 150(12):1862-7. PubMed ID: 8238643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye movement impairment and schizotypal psychopathology.
    Siever LJ; Friedman L; Moskowitz J; Mitropoulou V; Keefe R; Roitman SL; Merhige D; Trestman R; Silverman J; Mohs R
    Am J Psychiatry; 1994 Aug; 151(8):1209-15. PubMed ID: 8037257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria.
    Raine A
    Schizophr Bull; 1991; 17(4):555-64. PubMed ID: 1805349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?
    Cadenhead KS; Light GA; Geyer MA; McDowell JE; Braff DL
    Am J Psychiatry; 2002 May; 159(5):869-71. PubMed ID: 11986147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial transmission of schizotypal and borderline personality disorders.
    Baron M; Gruen R; Asnis L; Lord S
    Am J Psychiatry; 1985 Aug; 142(8):927-34. PubMed ID: 4025588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.